Drugs

, Volume 21, Issue 5, pp 374–382

Single Drug or Combination Therapy for Epilepsy?

  • E. H. Reynolds
  • S. D. Shorvon
Practical Therapeutics

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Coatsworth, J.J.: Studies on the Clinical Efficacy of Marketed Antiepileptic Drugs; NINDS Monograph No. 12 (US Government Printing Office, Washington DC 1971).Google Scholar
  2. Dellaportas, C.I.; Marshall, W.; Galbraith, A.W.; Shorvon, S.D. and Reynolds, E.H.: The evolution of chronic toxicity in previously untreated patients on phenytoin or carbamazepine. Communication to the 11th Epilepsy International Symposium, Florence 1979 (In press, 1981).Google Scholar
  3. Eadie, M.J. and Tyrer, J.H.: Anticonvulsant Therapy. Pharmacological Basis and Practice (Churchill Livingstone, Edinburgh 1980).Google Scholar
  4. Gastaut, H. and Osuntokun, B.O.: Proposals on antiepileptic pharmacotherapy for use in developing countries. Epilepsia 17: 355–360 (1976).PubMedCrossRefGoogle Scholar
  5. Guelen, P.J.M.; van der Kleijn, E. and Woudstra, U.: Statistical analysis of pharmacokinetic parameters in epileptic patients chronically treated with antiepileptic drugs; in Schneider et al. (Eds) Clinical Pharmacology of Antiepileptic Drugs, pp.2–10 (Springer-Verlag, Berlin 1975).CrossRefGoogle Scholar
  6. Milano Collaborative Group for Studies on Epilepsy: Long-term intensive monitoring in the difficult patient. Preliminary results of 16 months of observations — usefulness and limitations; in Gardner-Thorpe et al. (Eds) Antiepileptic Drug Monitoring, pp. 197–213 (Pitman, Tunbridge Wells 1977).Google Scholar
  7. Reynolds, E.H.: Serum levels of anticonvulsant drugs. Interpretation and clinical value. Pharmacology and Therapeutics 8: 217–235 (1980).PubMedCrossRefGoogle Scholar
  8. Reynolds, E.H. and Shorvon, S.D.: Monotherapy or polytherapy for epilepsy? Epilepsia 22: 1–10 (1981).PubMedCrossRefGoogle Scholar
  9. Rodin, E.A.: The Prognosis of Patients with Epilepsy (Thomas, Springfield, 1968).Google Scholar
  10. Schmidt, D.: One drug treatment with phenytoin in difficult-to-treat epilepsies with complex partial seizures: a preliminary report of a prospective study; in Johannessen et al. (Eds) Antiepileptic Therapy: Advances in Drug Monitoring, pp.221–228 (Raven Press, New York 1979).Google Scholar
  11. Shorvon, S.D. and Reynolds, E.H.: Unnecessary polypharmacy for epilepsy. British Medical Journal 1: 1635–1637 (1977).PubMedCrossRefGoogle Scholar
  12. Shorvon, S.D.; Chadwick, D.; Galbraith, A.W. and Reynolds, E.H.: One drug for epilepsy. British Medical Journal 1: 474–476 (1978).PubMedCrossRefGoogle Scholar
  13. Shorvon S.D. and Reynolds, E.H.: Reduction of polypharmacy for epilepsy. British Medical Journal 2: 1023–1025 (1979).PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Australasia Pty Ltd 1981

Authors and Affiliations

  • E. H. Reynolds
    • 1
  • S. D. Shorvon
    • 1
  1. 1.King’s College HospitalUniversity Department of NeurologyLondonEngland

Personalised recommendations